TTrialPathMatch Me to Trials
← Back to trials
RecruitingEarly Stage Breast Cancer

Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer

Eligible age

21–80 yrs

Accepts

Women

Locations

2 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This study will compare the effects on cardiorespiratory fitness (CRF) of aerobic exercise in different amounts (number of minutes/session) over different periods of time (number of weeks). Aerobic exercise is physical activity of light-to-moderate intensity that uses the large muscle groups (muscles in your legs, buttocks, back, and chest) and can be performed for at least 10 minutes. The researchers will study the effects of different exercise programs on how well the study participants' bodies use oxygen, how well their heart pumps blood, how well their lungs function, and how healthy their blood vessels are.

Sponsor: Memorial Sloan Kettering Cancer Center

You may qualify if…

  • Aged 21-80 years
  • Female
  • Surgically resected early stage (I-III) primary breast cancer
  • Post-menopausal, defined as one of the following:
  • Age ≥ 45 with no menses for at least 2 years
  • Chemically and/or surgically induced menopause through ovarian suppression, as determined by the primary oncologist
  • Estradiol level of ≤30 pg/mL
  • An interval of at least one year, but no more than five years, following the full completion of definitive therapy for malignant disease. Definitive therapy is defined as:

You may not qualify if…

  • Any of the following absolute contraindications to cardiopulmonary exercise testing:
  • Acute myocardial infarction within 3-5 days of any planned study procedures
  • Unstable angina
  • Uncontrolled arrhythmia causing symptoms or hemodynamic compromise
  • Recurrent syncope
  • Active endocarditis
  • Acute myocarditis or pericarditis
  • Symptomatic severe aortic stenosis

Where it's recruiting

Connecticut

Hartford

New York

New York

Source: ClinicalTrials.gov · NCT04458532 · last updated 2026-03-25